Trump 'comfortable with any outcome' from pivotal Xi talks - official
By Roberta Rampton WASHINGTON (Reuters) - U.S. President Donald Trump views this week's meeting with Chinese President Xi Jinping as a chance to see where Beijing stands on the countries' trade war, and is 'comfortable with any outcome' from the talks, a senior U.S. official said on Monday.
By Roberta Rampton
WASHINGTON (Reuters) - U.S. President Donald Trump views this week's meeting with Chinese President Xi Jinping as a chance to see where Beijing stands on the countries' trade war, and is "comfortable with any outcome" from the talks, a senior U.S. official said on Monday.
The much-anticipated meeting at the G20 summit in Osaka, Japan, will be the first time the leaders have met since late November - and their first face-to-face session since trade talks broke off in May, leading to a hike in U.S. tariffs on imports of Chinese goods.
The senior administration official, speaking to reporters on condition of anonymity, declined to give any details about plans for the meeting, other than to say it would likely happen on the second day of the Friday-Saturday summit.
"It's really just an opportunity for the president to maintain his engagement as he has very closely with his Chinese counterpart. Even as trade frictions persist, he's got the opportunity to see where the Chinese side is since the talks last left off," the official said.
"The president is quite comfortable with any outcome," the official added.
Trump, who is known for preferring one-on-one meetings to multilateral talks, will meet separately with at least eight world leaders while he is at the summit, the official said.
He plans to meet Russian President Vladimir Putin, Saudi Crown Prince Mohammed bin Salman and Turkish President Tayyip Erdogan, the official said, declining to give details of the dates and times because Trump's schedule was still in flux.
Trump also will meet with German Chancellor Angela Merkel, Indian Prime Minister Narendra Modi, Australian Prime Minister Scott Morrison and Japanese Prime Minister Shinzo Abe, who is hosting the summit, the official told reporters on a conference call, noting additional bilateral meetings could still be announced.
(Reporting by Roberta Rampton; Additional reporting by Eric Beech and Mohammad Zargham; Editing by G Crosse and Peter Cooney)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
(Reuters) - Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter. A deal for Immunomedics, which last month reported positive data from a late-stage study for its breast-cancer drug, could be announced Monday if not sooner, the Journal said https://www.wsj.com/articles/gilead-nears-deal-to-buy-immunomedics-for-more-than-20-billion-11599936777?mod=hp_lead_pos2. Gilead and Immunomedics did not respond immediately to emailed requests from Reuters for comment
SHANGHAI (Reuters) - China banned pork imports from Germany on Saturday after it confirmed its first case of African swine fever last week, in a move set to hit German producers and push up global prices as China's meat supplies tighten. China's ban on imports from its third largest supplier comes as the world's top meat buyer deals with an unprecedented pork shortage after its own epidemic of the deadly hog disease. The ban on Germany, which has supplied about 14% of China's pork imports so far this year, will push up demand for meat from other major suppliers like the United States and Spain, boosting global prices.
CAIRO (Reuters) - Libyan commander Khalifa Haftar has committed to ending a months-long blockade of oil facilities, the U.S.